Should treatment of low-level rifampicin mono-resistant tuberculosis be different?

Autor: Gopie, F.A., Commiesie, E., Baldi, S., Kamst, M., Kaur, D., de Lange, W.C.M., Pinas, P.S., Stijnberg, D., Wongsokarijo, M., Zijlmans, C.W.R., de Zwaan, R., van Soolingen, D., Vreden, S.G.S., de Vries, G.

Publikováno v: In Journal of Clinical Tuberculosis and Other Mycobacterial Diseases May 2021 23

Corrigendum to ‘Should treatment of low-level rifampicin mono-resistant tuberculosis be different?’ [JCTUBE 23 (2021) 100241]

Autor: Gopie, F.A., Commiesie, E., de Lange, W.C.M., van Soolingen, D., Vreden, S.G.S., de Vries, G.

Publikováno v: In Journal of Clinical Tuberculosis and Other Mycobacterial Diseases August 2021 24

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Key drivers of the TB epidemic in Suriname and priority actions to reduce incidence and mortality.

Autor: Commiesie E; National Tuberculosis Programme, Paramaribo.; Anton de Kom University, Paramaribo, Suriname., Stijnberg D; National Tuberculosis Programme, Paramaribo.; Anton de Kom University, Paramaribo, Suriname., van den Boogaard J; National Institute for Public Health and the Environment (RIVM), Bilthoven, The Netherlands., Gopie F; Anton de Kom University, Paramaribo, Suriname.; Academic Hospital, Paramaribo, Suriname., Vreden S; Anton de Kom University, Paramaribo, Suriname., de Vries G; Anton de Kom University, Paramaribo, Suriname.; National Institute for Public Health and the Environment (RIVM), Bilthoven, The Netherlands.

Publikováno v: IJTLD open [IJTLD Open] 2024 Jan 01; Vol. 1 (1), pp. 34-40. Date of Electronic Publication: 2024 Jan 01 (Print Publication: 2024).